IMHA, or immune-mediated hemolytic anemia, is a condition where a cat’s immune system mistakenly attacks and destroys its own red blood cells. Red blood cells carry oxygen throughout the body, so when they’re destroyed faster than the bone marrow can replace them, the cat becomes severely anemic. IMHA is less common in cats than in dogs, but it can be life-threatening without prompt treatment.
How IMHA Destroys Red Blood Cells
In a healthy cat, the immune system recognizes red blood cells as “self” and leaves them alone. In IMHA, the immune system produces antibodies that latch onto the surface of red blood cells, marking them for destruction. The body then breaks these tagged cells down in the spleen, liver, or directly in the bloodstream. This process can happen gradually or very rapidly, sometimes dropping a cat’s red blood cell count to dangerously low levels within days.
When red blood cells are destroyed in the bloodstream, they release their contents, which can give the skin, gums, and whites of the eyes a yellowish tint (jaundice). The cat’s body tries to compensate by pushing immature red blood cells out of the bone marrow early, but in many cases, production simply can’t keep pace with destruction.
Primary vs. Secondary IMHA
Veterinarians classify IMHA into two types based on whether a trigger can be identified. Primary (or idiopathic) IMHA means the immune system attacks red blood cells for no detectable reason. Secondary IMHA means something else provoked the immune response.
The most well-documented infectious trigger in cats is a blood parasite called Mycoplasma haemofelis, a type of bacteria spread by fleas and ticks that attaches to red blood cells. Strong evidence links this organism to IMHA in cats across multiple studies. Other infections associated with IMHA include feline infectious peritonitis (FIP), feline immunodeficiency virus (FIV), and a tick-borne parasite called Babesia felis, though some of these links are less well established.
Cancer can also trigger IMHA. Across five published studies, 21 cats with both cancer and IMHA were identified. Lymphoma was the most common cancer type, followed by other blood and bone marrow cancers. Solid tumors are a rarer trigger.
Certain medications have been implicated as well. Propylthiouracil, a drug once used to treat hyperthyroidism in cats, caused immune-mediated reactions in 7 out of 105 cats in one study. This drug is now rarely prescribed for cats partly because of this risk. Rat poison (warfarin) exposure has also been linked to IMHA in at least one documented case.
Signs You Might Notice at Home
Because IMHA causes anemia, the signs reflect a body starved of oxygen. The most common things cat owners notice include:
- Lethargy and weakness: your cat may sleep more, move less, or seem uninterested in food or play
- Pale or white gums: healthy cat gums are pink, so checking gum color is one of the quickest ways to spot anemia
- Rapid breathing or panting: the body compensates for fewer red blood cells by breathing faster to pull in more oxygen
- Elevated heart rate: the heart pumps harder to circulate the reduced supply of oxygen-carrying cells
- Jaundice: a yellow tinge to the gums, inner ears, or whites of the eyes, caused by pigments released from destroyed red blood cells
- Dark or orange-red urine: breakdown products from red blood cells can discolor the urine
These signs can develop over several days or appear suddenly. Some cats seem fine one day and collapse the next, especially when red blood cell destruction is rapid.
Which Cats Are at Risk
A study examining demographic patterns in cats with primary IMHA found no breed or sex predisposition. However, young adult cats between roughly 2 and 6 years old were more likely to develop primary IMHA than other age groups. Earlier reports had suggested male cats might be at higher risk, but this larger analysis did not confirm that.
Cats with underlying infections or cancer are at risk for secondary IMHA at any age. Outdoor cats face higher exposure to flea- and tick-borne organisms like Mycoplasma haemofelis, which makes flea and tick prevention relevant to reducing risk.
How Vets Diagnose IMHA
Diagnosis starts with blood work. A complete blood count reveals how low the red blood cell level has dropped, measured as packed cell volume (PCV) or hematocrit. Normal PCV in cats is roughly 30 to 45 percent. Cats with IMHA often present well below that range.
Beyond confirming anemia, the vet looks for evidence that the immune system is causing the destruction. One quick test mixes a drop of blood with saline on a glass slide. If the red blood cells clump together (autoagglutination), it strongly suggests antibodies are coating them. A more sensitive test, called a Coombs test, detects antibodies bound to red blood cell surfaces even when clumping isn’t visible to the naked eye.
A blood smear examined under a microscope can reveal spherocytes, which are red blood cells that have been partially chewed up by immune cells and taken on a smaller, rounder shape. The smear also shows whether the bone marrow is responding by releasing immature red blood cells (called reticulocytes) into circulation.
Because secondary IMHA is common in cats, vets typically test for underlying causes. This often includes screening for feline leukemia virus, FIV, and Mycoplasma haemofelis, along with imaging to check for tumors. Identifying and treating the underlying trigger is critical when secondary IMHA is involved.
Treatment and What to Expect
The immediate priority is stabilizing a cat whose red blood cell count has dropped to dangerous levels. If PCV falls to around 13 percent or lower, or the cat is visibly weak, pale, and breathing rapidly, a blood transfusion is typically necessary. Transfusions buy time by temporarily boosting the oxygen-carrying capacity of the blood while other treatments take effect.
The core of IMHA treatment is suppressing the immune system so it stops destroying red blood cells. In a UK referral hospital study of 30 cats, 86 percent were started on prednisolone alone as the first-line treatment. A smaller number (10 percent) received prednisolone combined with cyclosporine, a second immune-suppressing drug. Prednisolone is a steroid that broadly dials down immune activity, and most cats that respond to treatment achieve a normal red blood cell count on prednisolone alone.
For cats that don’t respond well to prednisolone by itself, vets may add a second medication. Options include cyclosporine, mycophenolate, or chlorambucil, each of which suppresses the immune system through a different pathway. In the same study, about half of the cats that needed a treatment change received a combination approach.
Treatment is not short-term. Cats that respond well typically stay on medication for weeks to months, with the dose gradually tapered as blood counts stabilize. Dropping the dose too quickly risks relapse, so vets monitor blood work regularly during the tapering process to ensure red blood cell levels hold steady.
Potential Complications
The most dangerous complication of IMHA is blood clot formation. In dogs, clots in the lungs (pulmonary thromboembolism) and a clotting disorder called disseminated intravascular coagulation are the leading causes of death from IMHA. The situation in cats is less well studied. Pulmonary blood clots secondary to IMHA have been documented in cats, but only in a small number of reported cases, and the true frequency remains unknown.
The destruction of large numbers of red blood cells also puts strain on the liver and kidneys, which must process the breakdown products. Jaundice is a visible sign of this burden. In severe cases, organ function can be compromised. Cats receiving immune-suppressing medications are also more vulnerable to infections while their immune systems are dialed down, so monitoring for secondary infections matters during treatment.
Prognosis and Recovery
Survival rates for feline IMHA vary depending on whether the cause is primary or secondary, how quickly treatment begins, and how severe the anemia is at diagnosis. In the UK study of 30 cats, 18 out of 30 (60 percent) achieved a normal red blood cell count during treatment. Some cats recover fully and eventually come off medication without relapsing. Others need long-term low-dose treatment to keep the condition in check.
Cats with secondary IMHA generally have a better outlook when the underlying trigger, whether an infection or a drug reaction, can be identified and addressed. Primary IMHA, where no trigger is found, carries a higher risk of relapse because there’s nothing specific to treat beyond the immune dysfunction itself. Regular follow-up blood work during and after treatment helps catch any early signs of a red blood cell count dropping again.